Curtis, David;
(2023)
The PREPARE study: benefits of pharmacogenetic testing are unclear.
The Lancet
, 401
(10391)
pp. 1850-1851.
10.1016/S0140-6736(23)00854-1.
Preview |
Text
Curtis_PharmacogeneticsLetter.20230203.pdf Download (132kB) | Preview |
| Type: | Article |
|---|---|
| Title: | The PREPARE study: benefits of pharmacogenetic testing are unclear |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S0140-6736(23)00854-1 |
| Publisher version: | http://dx.doi.org/10.1016/s0140-6736(23)00854-1 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Genetics, Evolution and Environment |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10184544 |
Downloads since deposit
550Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
